- Home
- ATIP vs ORGS Comparison
ATIP vs ORGS Comparison
Compare ATIP & ORGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATIP
- ORGS
- Stock Information
- Founded
- ATIP 1996
- ORGS 2008
- Country
- ATIP United States
- ORGS United States
- Employees
- ATIP N/A
- ORGS N/A
- Industry
- ATIP Hospital/Nursing Management
- ORGS Biotechnology: Pharmaceutical Preparations
- Sector
- ATIP Health Care
- ORGS Health Care
- Exchange
- ATIP Nasdaq
- ORGS Nasdaq
- Market Cap
- ATIP 26.0M
- ORGS 24.9M
- IPO Year
- ATIP N/A
- ORGS N/A
- Fundamental
- Price
- ATIP $6.24
- ORGS $3.25
- Analyst Decision
- ATIP
- ORGS
- Analyst Count
- ATIP 0
- ORGS 0
- Target Price
- ATIP N/A
- ORGS N/A
- AVG Volume (30 Days)
- ATIP 7.9K
- ORGS 31.5K
- Earning Date
- ATIP 11-04-2024
- ORGS 11-11-2024
- Dividend Yield
- ATIP N/A
- ORGS N/A
- EPS Growth
- ATIP N/A
- ORGS N/A
- EPS
- ATIP N/A
- ORGS N/A
- Revenue
- ATIP $717,149,000.00
- ORGS $662,000.00
- Revenue This Year
- ATIP $10.99
- ORGS $13,429.43
- Revenue Next Year
- ATIP $5.98
- ORGS N/A
- P/E Ratio
- ATIP N/A
- ORGS N/A
- Revenue Growth
- ATIP 11.00
- ORGS N/A
- 52 Week Low
- ATIP $3.92
- ORGS $2.50
- 52 Week High
- ATIP $8.48
- ORGS $10.80
- Technical
- Relative Strength Index (RSI)
- ATIP 60.27
- ORGS 35.76
- Support Level
- ATIP $5.66
- ORGS $2.76
- Resistance Level
- ATIP $6.46
- ORGS $3.49
- Average True Range (ATR)
- ATIP 0.30
- ORGS 0.38
- MACD
- ATIP 0.01
- ORGS -0.01
- Stochastic Oscillator
- ATIP 72.50
- ORGS 22.13
About ATIP ATI Physical Therapy Inc.
ATI Physical Therapy Inc is a recognized outpatient physical therapy provider in the United States specializing in outpatient rehabilitation and adjacent healthcare services. It offer a variety of services within the clinics, including physical therapy to treat spine, shoulder, knee and neck injuries or pain; work injury rehabilitation services, including work conditioning and work hardening; hand therapy; and other specialized treatment services.
About ORGS Orgenesis Inc.
Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Octomera and Therapies.